DK134906C - - Google Patents

Info

Publication number
DK134906C
DK134906C DK619172A DK619172A DK134906C DK 134906 C DK134906 C DK 134906C DK 619172 A DK619172 A DK 619172A DK 619172 A DK619172 A DK 619172A DK 134906 C DK134906 C DK 134906C
Authority
DK
Denmark
Application number
DK619172A
Other languages
Danish (da)
Other versions
DK134906B (da
Inventor
A Holmes
R F Meyer
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of DK134906B publication Critical patent/DK134906B/da
Application granted granted Critical
Publication of DK134906C publication Critical patent/DK134906C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK619172AA 1971-12-14 1972-12-12 Analogifremgangsmåde til fremstilling af 1-(3,4-dimethoxyphenethylamino)-3(substitueret phenoxy)-2-propanoler. DK134906B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00207954A US3857891A (en) 1971-12-14 1971-12-14 New aminoalkanol compounds and methods for their production

Publications (2)

Publication Number Publication Date
DK134906B DK134906B (da) 1977-02-07
DK134906C true DK134906C (en:Method) 1977-06-27

Family

ID=22772656

Family Applications (1)

Application Number Title Priority Date Filing Date
DK619172AA DK134906B (da) 1971-12-14 1972-12-12 Analogifremgangsmåde til fremstilling af 1-(3,4-dimethoxyphenethylamino)-3(substitueret phenoxy)-2-propanoler.

Country Status (21)

Country Link
US (1) US3857891A (en:Method)
JP (1) JPS5233621B2 (en:Method)
AR (2) AR195896A1 (en:Method)
AT (1) AT317182B (en:Method)
AU (1) AU475446B2 (en:Method)
BE (1) BE790165A (en:Method)
CA (1) CA993889A (en:Method)
CH (1) CH551371A (en:Method)
DK (1) DK134906B (en:Method)
ES (1) ES409565A1 (en:Method)
FI (1) FI55650C (en:Method)
FR (1) FR2163486B1 (en:Method)
GB (1) GB1344976A (en:Method)
HU (1) HU164953B (en:Method)
IE (1) IE37701B1 (en:Method)
IL (1) IL40833A (en:Method)
NL (1) NL150101B (en:Method)
NO (1) NO135244C (en:Method)
SE (1) SE393104B (en:Method)
YU (2) YU35871B (en:Method)
ZA (1) ZA727078B (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119843B1 (en:Method) * 1970-12-28 1974-03-22 Laroche Navarro Labo
JPS5653534B2 (en:Method) * 1973-10-25 1981-12-19
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
JPS56158868A (en) * 1980-05-13 1981-12-07 Satake Eng Co Ltd Ion nitriding treatment device
ZA852843B (en) * 1984-05-15 1985-11-27 Warner Lambert Co Bevantolol preparation
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4789751A (en) * 1985-10-01 1988-12-06 University Patents, Inc. Synthesis of new liquid crystal materials possessing phenylbenzoate or biphenyl core units and (2,3)-epoalkyloxirane methanol chiral tails
JP2587336B2 (ja) * 1991-10-03 1997-03-05 日本ケミファ株式会社 塩酸ベバントロールの製造方法
US5482964A (en) * 1994-10-11 1996-01-09 Warner-Lambert Company Substituted phenoxyhydroxypropyl amines as central nervous system agents
TW467881B (en) * 1997-07-31 2001-12-11 Ying-Jiun Chen Guaiacoxypropanolamines with Α/β-adrenergic blocking activity
AU8527798A (en) * 1998-07-23 2000-02-14 Ing-Jun Chen Guaiacoxypropanolamine derivatives with alpha/beta-adrenergic blocking activity
EP1545519B1 (en) 2002-08-19 2011-03-23 Pfizer Inc. Combination therapy for hyperproliferative diseases
CN1812983A (zh) 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
CN1884251B (zh) * 2005-06-22 2010-06-23 北京德众万全医药科技有限公司 一种盐酸贝凡洛尔的精制方法
SG166829A1 (en) 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
BR112015031835B1 (pt) * 2013-06-19 2022-12-13 Som Innovation Biotech, S.L Usos de agentes terapêuticos, de uma combinação dos referidos agentes com um agente terapêutico adicional, e de uma composição farmacêutica para fabricação de medicamento para a profilaxia e/ou tratamento de distúrbios do movimento hipercinético

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300886A (en:Method) * 1962-11-23
NL301580A (en:Method) * 1962-12-11
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives

Also Published As

Publication number Publication date
YU35871B (en) 1981-08-31
YU293979A (en) 1981-04-30
YU36007B (en) 1981-11-13
US3857891A (en) 1974-12-31
SE393104B (sv) 1977-05-02
YU301972A (en) 1981-02-28
AT317182B (de) 1974-08-12
FI55650B (fi) 1979-05-31
DK134906B (da) 1977-02-07
IL40833A (en) 1976-01-30
IE37701B1 (en) 1977-09-28
JPS5233621B2 (en:Method) 1977-08-30
ZA727078B (en) 1973-06-27
ES409565A1 (es) 1975-12-01
AU475446B2 (en) 1976-08-26
AR195896A1 (es) 1973-11-15
FR2163486B1 (en:Method) 1976-03-05
BE790165A (fr) 1973-02-15
FR2163486A1 (en:Method) 1973-07-27
DE2259489A1 (de) 1973-07-05
NL150101B (nl) 1976-07-15
NO135244C (en:Method) 1977-03-09
HU164953B (en:Method) 1974-05-28
CA993889A (en) 1976-07-27
IE37701L (en) 1973-05-14
CH551371A (fr) 1974-07-15
AR198442A1 (es) 1974-06-21
NO135244B (en:Method) 1976-11-29
JPS4867232A (en:Method) 1973-09-13
GB1344976A (en) 1974-01-23
FI55650C (fi) 1979-09-10
AU4918672A (en) 1974-05-23
DE2259489B2 (de) 1976-02-26
NL7216281A (en:Method) 1973-06-18
IL40833A0 (en) 1973-01-30

Similar Documents

Publication Publication Date Title
FR2163486B1 (en:Method)
FR2141251A5 (en:Method)
AU2684171A (en:Method)
AU2669471A (en:Method)
CH562693A5 (en:Method)
CH1751771A4 (en:Method)
CH580662A5 (en:Method)
CH561164A5 (en:Method)
CH573973A5 (en:Method)
BG16669A1 (en:Method)
BG16875A1 (en:Method)
CH571488A5 (en:Method)
CH570461A5 (en:Method)
CH584455A5 (en:Method)
CH1058872A4 (en:Method)
BE774315A (en:Method)
CH575994A5 (en:Method)
CH590871A5 (en:Method)
CH1793872A4 (en:Method)
CH566715A5 (en:Method)
CH578235A5 (en:Method)
CH545724A (en:Method)
CH562422A5 (en:Method)
CH586672A5 (en:Method)
BE792077A (en:Method)

Legal Events

Date Code Title Description
PUP Patent expired